These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17956259)

  • 61. Structure-based drug design: exploring the proper filling of apolar pockets at enzyme active sites.
    Zürcher M; Diederich F
    J Org Chem; 2008 Jun; 73(12):4345-61. PubMed ID: 18510366
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Picking pockets to fuel antimicrobial drug discovery.
    Hunter WN
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):980-4. PubMed ID: 17956259
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Structure-based design of anti-infectives.
    Agarwal AK; Fishwick CW
    Ann N Y Acad Sci; 2010 Dec; 1213():20-45. PubMed ID: 21175675
    [TBL] [Abstract][Full Text] [Related]  

  • 64. New targets and screening approaches in antimicrobial drug discovery.
    Brown ED; Wright GD
    Chem Rev; 2005 Feb; 105(2):759-74. PubMed ID: 15700964
    [No Abstract]   [Full Text] [Related]  

  • 65. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Isoprenoid biosynthetic pathways as anti-infective drug targets.
    Rohdich F; Bacher A; Eisenreich W
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):785-91. PubMed ID: 16042599
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Folate biosynthesis pathway: mechanisms and insights into drug design for infectious diseases.
    Bertacine Dias MV; Santos JC; Libreros-Zúñiga GA; Ribeiro JA; Chavez-Pacheco SM
    Future Med Chem; 2018 Apr; 10(8):935-959. PubMed ID: 29629843
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [The possibility of drug design of quinolones effective for multiresistant gram-positive pathogens].
    Hayakawa I
    Nihon Rinsho; 1997 May; 55(5):1266-71. PubMed ID: 9155185
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Structural biology in fragment-based drug design.
    Murray CW; Blundell TL
    Curr Opin Struct Biol; 2010 Aug; 20(4):497-507. PubMed ID: 20471246
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bioconverted products of essential fatty acids as potential antimicrobial agents.
    Bajpai VK; Kim HR; Hou CT; Kang SC
    N Biotechnol; 2009 Oct; 26(3-4):122-30. PubMed ID: 19643210
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Druggability of the enzymes of the non-mevalonate-pathway.
    Masini T; Kroezen BS; Hirsch AK
    Drug Discov Today; 2013 Dec; 18(23-24):1256-62. PubMed ID: 23856326
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Coenzyme A biosynthesis: an antimicrobial drug target.
    Spry C; Kirk K; Saliba KJ
    FEMS Microbiol Rev; 2008 Jan; 32(1):56-106. PubMed ID: 18173393
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Riboflavin biosynthetic and regulatory factors as potential novel anti-infective drug targets.
    Long Q; Ji L; Wang H; Xie J
    Chem Biol Drug Des; 2010 Apr; 75(4):339-47. PubMed ID: 20148904
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Isocyanide-based multicomponent reactions in drug discovery.
    Akritopoulou-Zanze I
    Curr Opin Chem Biol; 2008 Jun; 12(3):324-31. PubMed ID: 18312861
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.